Pharvaris N.V. PHVS

PHVS Quotes by TradingView
Institutional shares held 39.1 Million
0 calls
0 puts
Total value of holdings $666M
$0 calls
$0 puts
Market Cap $583M
33,766,000 Shares Out.
Institutional ownership 115.68%
# of Institutions 53

Quarterly Institutional Activity in PHVS

Shares Bought
Shares Sold
View Transactions

Top Institutions Holding PHVS

View all
View all

Latest Institutional Activity in PHVS

Top Purchases

Q1 2025
Palumbo Wealth Management LLC Shares Held: 14.1K ($244K)
3.88K Shares purchased
37.97% Added
Q4 2024
Soleus Capital Management, L.P. Shares Held: 815K ($14.1M)
216K Shares purchased
36.19% Added
Q4 2024
Octagon Capital Advisors LP Shares Held: 778K ($13.4M)
158K Shares purchased
25.39% Added
Q4 2024
Price T Rowe Associates Inc Shares Held: 444K ($7.67M)
118K Shares purchased
36.38% Added
Q4 2024
Northern Trust Corp Shares Held: 91.9K ($1.59M)
76.2K Shares purchased
483.92% Added
View All Buyers

Top Sells

Q1 2025
Alps Advisors Inc Shares Held: 36.6K ($633K)
7.04K Shares sold
16.12% Reduced
Q4 2024
Vr Adviser, LLC Shares Held: 3.22M ($55.6M)
175K Shares sold
5.17% Reduced
Q4 2024
Sphera Funds Management Ltd. Shares Held: 388K ($6.7M)
51.1K Shares sold
11.63% Reduced
Q4 2024
Sofinnova Investments, Inc. Shares Held: 561K ($9.68M)
39.6K Shares sold
6.59% Reduced
Q4 2024
Patient Square Capital LP Shares Held: 208K ($3.59M)
34.7K Shares sold
14.33% Reduced
View All Sellers

About PHVS

Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks and is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients and is under Phase 1 clinical trial. It operates in the Netherlands, Switzerland, and the United States. The company was incorporated in 2015 and is based in Leiden, the Netherlands.

PHVS Chart by TradingView
PHVS Fundamental Data by TradingView

Insider Transactions at PHVS

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
0 Shares
From 0 Insiders
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on PHVS

Follow Pharvaris N.V. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHVS shares.

Notify only if
Any

Insider Trading

Get notified when an Pharvaris N.V. insider buys or sells PHVS shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Pharvaris N.V.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PHVS